Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
Woman Max 99 years
Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
Update Il y a 4 ans
MLN0128 in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy. MLN0128 en combinación con Fulvestrant en mujeres con cáncer de mama avanzado o metastásico después de un tratamiento con inhibidores de la aromatasa
- To compare the PFS of patients treated with the combination of fulvestrant+daily MLN0128 versus patients treated with single-agent fulvestrant. - To compare the PFS of patients treated with the comb...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
Update Il y a 4 ans
The aim of the study is to provide patients with certain kinds of cancer continued access to the same drug they have received in a previous study, if they have benefited from the use of the drug. El objetivo de este estudio seguir ofreciendo a los pacientes acceso al mismo medicamento que han venido recibiendo en un estudio previo, si han tenido beneficio del uso del medicamento
Primary Objective: To provide continued access of ixazomib and to evaluate the long-term safety profile of ixazomib. Objetivo Principal: Seguir ofreciendo acceso a ixazomib y evaluar la segurida...
Country
None
organs
None
Specialty
None
unknown
More information
